Postherpetic Neuralgia
📧 Sign up to get email alerts when something new happens for Postherpetic Neuralgia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia [Phase 4]
Phase 4 pilot study evaluating pregabalin for treatment response prediction in postherpetic neuralgia; the trial was terminated and results …
-
CLINICAL_TRIALS trial_result · 2014-06-19Clinical Trial Update: Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia [Phase 2]
A Phase 2 trial evaluating NXN-462 for postherpetic neuralgia reports on its efficacy, tolerability, and safety; the study is completed.
-
CLINICAL_TRIALS trial_result · 2014-05-12Clinical Trial Update: Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN) [Phase 2]
Phase 2 clinical trial evaluating the analgesic efficacy and safety of V116517 in adults with moderate to severe pain due to postherpetic ne…
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain [Phase 4]
Phase 4 clinical trial update shows completion of oxcarbazepine for chronic peripheral neuropathic pain, including polyneuropathy, periphera…
-
CLINICAL_TRIALS trial_result · 2014-04-11Clinical Trial Update: Leech Therapy for Postherpetic Neuralgia
A clinical trial evaluating leech therapy for postherpetic neuralgia sponsored by Universität Duisburg-Essen was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Eslicarbazepine Acetate as Therapy in Post-Herpetic Neuralgia [Phase 3]
Phase 3 clinical trial of eslicarbazepine acetate for postherpetic neuralgia was terminated; results were posted in 2014.
-
FDA approval · 2014-03-25FDA Approved: GABAPENTIN — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for gabapentin from BluePoint Laboratories, granting approval of a generic version under ANDA077…
-
CLINICAL_TRIALS trial_result · 2014-02-21Clinical Trial Update: Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic Neuralgia [Phase 2]
A Phase 2 trial evaluated the efficacy and safety of DWP05195 in subjects with postherpetic neuralgia, and the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: Efficacy and Safety Study of Z160 in Subjects With Postherpetic Neuralgia [Phase 2]
Phase 2 trial evaluating the efficacy and safety of Z160 in adults with postherpetic neuralgia has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN) [Phase 2]
Phase 2 trial evaluating levetiracetam for postherpetic neuralgia has completed. The update provides status but does not report efficacy or …
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: A Crossover Study to Evaluate the Safety, Tolerability and Efficacy of XPF-002 in Subjects With Postherpetic Neuralgia (PHN) [Phase 2]
Phase 2 crossover study evaluating XPF-002 for postherpetic neuralgia. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2013-11-15Clinical Trial Update: A Study of the Safety and Efficacy of AGN-214868 in Patients With Postherpetic Neuralgia [Phase 2]
Allergan's Phase 2 trial of AGN-214868 for postherpetic neuralgia has completed, and results were posted in 2013.
-
FDA approval · 2013-10-29FDA Approved: HORIZANT — Supplemental Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))
The FDA approved a supplemental application for Horizant (gabapentin enacarbil) from Azurity Pharmaceuticals (formerly Arbor Pharmaceuticals…
-
CLINICAL_TRIALS trial_result · 2013-10-10Clinical Trial Update: A Comparative Study of KHK6188 [Phase 2]
This document reports the completion of a Phase 2 comparative study of KHK6188 for postherpetic neuralgia.
-
FDA approval · 2013-09-09FDA Approved: GRALISE — Supplemental Application (Almatica Pharma LLC)
FDA approved a supplemental application for GRALISE (gabapentin) submitted by Almatica Pharma LLC.
-
FDA approval · 2013-07-31FDA Approved: GRALISE — Supplemental Application (Almatica Pharma LLC)
The FDA approved a supplemental application for GRALISE (gabapentin) submitted by Almatica Pharma LLC.
-
CLINICAL_TRIALS trial_result · 2013-07-25Clinical Trial Update: A Confirmatory Study of Fentanyl in Participants With Post-herpetic Neuralgia, Complex Regional Pain Syndrome or Postoperative Pain Syndrome [Phase 3]
A Phase 3 confirmatory study of fentanyl in participants with postherpetic neuralgia, complex regional pain syndrome, or postoperative pain …
-
FDA approval · 2013-07-12FDA Approved: GABAPENTIN — Original Application (ACI Healthcare USA, Inc.)
FDA approved a generic gabapentin product under an Original Application filed by ACI Healthcare USA, Inc.
-
CLINICAL_TRIALS trial_result · 2013-07-04Clinical Trial Update: Shingles Prevention Study [Phase 3]
Phase 3 results from the Shingles Prevention Study have completed, evaluating a shingles vaccine for prevention of herpes zoster and posther…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: A Phase 2 Study of Tapentadol Extended-Release (JNS024ER) ) in Japanese Participants With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic Neuralgia [Phase 2]
This update summarizes results from a Phase 2 study of tapentadol extended-release (JNS024ER) in Japanese participants with chronic pain due…
-
FDA approval · 2013-06-10FDA Approved: GRALISE — Supplemental Application (Almatica Pharma LLC)
FDA approved a supplemental application for GRALISE (gabapentin) from Almatica Pharma LLC.
-
CLINICAL_TRIALS withdrawal · 2013-05-31Clinical Trial Update: Efficacy, Safety, Tolerability and Pharmacokinetics of Concomitant Administration of Tramadol With Duloxetine or Pregabalin [Phase 4]
A Phase 4 clinical trial evaluating the concomitant use of tramadol with duloxetine or pregabalin has been withdrawn. The study involved pat…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Efficacy and Safety of Eslicarbazepine Acetate as Therapy for Patients With Post-Herpetic Neuralgia [Phase 2]
Phase 2 trial results report efficacy and safety of eslicarbazepine acetate for postherpetic neuralgia, with the study completed and results…
-
FDA approval · 2013-05-01FDA Approved: HORIZANT — Supplemental Application (Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals))
FDA approved a supplemental application for Horizant (gabapentin enacarbil) by Azurity Pharmaceuticals, Inc.
-
FDA approval · 2013-04-09FDA Approved: GABAPENTIN — Supplemental Application (Advagen Pharma Ltd)
FDA approved a supplemental application for gabapentin submitted by Advagen Pharma Ltd.